Header cover image

Belgian (BEL20) Healthcare Sector Analysis

UpdatedMay 31, 2023
DataAggregated Company Financials
Companies15
  • 7D-6.0%
  • 3M1.3%
  • 1Y6.0%
  • YTD4.4%

Over the last 7 days, the Healthcare industry has dropped 4.3%, driven by declines in UCB and argenx of 7.6% and 5.1%, respectively. On the other hand Onward Medical is actually up 17%. In the past year, the industry has gained 6.8%. As for the next few years, earnings are expected to grow by 52% per annum.

Sector Valuation and Performance

Has the Belgian Healthcare Sector valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Wed, 31 May 2023€41.7b€9.1b-€359,484,305.0036x-116x4.6x
Fri, 28 Apr 2023€41.8b€8.9b-€264,857,485.0028.1x-157.8x4.7x
Sun, 26 Mar 2023€39.8b€8.9b-€286,128,158.0025.7x-139.2x4.5x
Tue, 21 Feb 2023€40.6b€9.1b€139.8m16.1x290.5x4.5x
Thu, 19 Jan 2023€41.4b€9.0b€128.4m15.7x322.4x4.6x
Sat, 17 Dec 2022€40.2b€9.0b€111.2m14.4x362x4.5x
Mon, 14 Nov 2022€39.4b€9.0b€86.8m14.4x453.8x4.4x
Wed, 12 Oct 2022€40.1b€8.9b€42.9m14.3x935.6x4.5x
Fri, 09 Sep 2022€41.2b€8.8b€72.9m14.4x565.5x4.7x
Sun, 07 Aug 2022€40.5b€8.8b€183.2m15.2x221.1x4.6x
Tue, 05 Jul 2022€42.3b€8.9b€603.9m16.4x70x4.8x
Thu, 02 Jun 2022€38.4b€8.9b€650.8m17x59x4.3x
Sat, 30 Apr 2022€43.5b€9.0b€842.2m20.4x51.7x4.9x
Mon, 28 Mar 2022€42.9b€9.0b€839.5m19.6x51.1x4.8x
Wed, 23 Feb 2022€37.1b€8.7b€744.3m15x49.8x4.3x
Fri, 21 Jan 2022€38.9b€8.6b€738.3m15x52.7x4.5x
Sun, 19 Dec 2021€41.0b€8.6b€736.1m15x55.6x4.7x
Tue, 16 Nov 2021€42.5b€8.6b€743.2m16.1x57.2x4.9x
Thu, 14 Oct 2021€40.1b€8.6b€756.6m15.9x52.9x4.7x
Sat, 11 Sep 2021€40.4b€8.6b€797.3m12.6x50.7x4.7x
Mon, 09 Aug 2021€37.0b€8.6b€461.9m19.2x80.1x4.3x
Sun, 02 May 2021€32.0b€8.2b€98.8m17.5x323.4x3.9x
Wed, 03 Feb 2021€32.5b€8.1b-€97,657,450.0022.1x-332.6x4x
Sat, 07 Nov 2020€30.2b€8.0b-€6,843,256.6021.5x-4420.3x3.8x
Fri, 31 Jul 2020€33.8b€8.1b€164.0m26.6x206x4.2x
Price to Earnings Ratio

106.3x


Total Market Cap: €30.2bTotal Earnings: €283.6mTotal Revenue: €8.0bTotal Market Cap vs Earnings and Revenue0%0%0%
Belgian Healthcare Sector Price to Earnings3Y Average -280.6x202120222023
Current Industry PE
  • Investors are relatively neutral on the Belgian Healthcare industry at the moment, indicating that they anticipate long term growth rates to remain steady.
  • The industry is trading close to its 3-year average PS ratio of 4.4x.
Past Earnings Growth
  • Total earnings for the Healthcare industry have declined over the last three years, with the industry now making a loss overall.
  • Meanwhile revenues have grown 4.3% per year.
  • This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.

Industry Trends

Which industries have driven the changes within the Belgian Healthcare sector?

BE Market-3.44%
Healthcare-5.97%
Medical Equipment3.53%
Life Sciences0%
Healthcare Services-0.99%
Biotech-5.04%
Healthtech-5.43%
Pharma-7.69%
Industry PE
  • Investors are most optimistic about the Pharma industry which is trading above its 3-year average PE ratio of 22.9x.
    • Analysts are expecting annual earnings growth of 25.4%, which is higher than its past year's earnings decline of 29.2% per year.
Forecasted Growth
  • Analysts are most optimistic on the Healthtech industry, expecting annual earnings growth of 113% over the next 5 years.
  • In contrast, the Healthcare Services industry is expected to see its earnings grow by 12% per year over the next few years.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
ONWD Onward Medical€5.7016.8%
+€24.8m
-15.6%PS80.1x
NYXH Nyxoah€7.166.9%
+€13.2m
-39.3%PS71.6x
SEQUA Sequana Medical€3.235.9%
+€5.1m
-43.5%PS98.7x
OXUR Oxurion€0.005335.9%
+€953.9k
-98.6%PS6.1x
BIOS BioSenic€0.124.7%
+€682.0k
n/an/a
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

ARGX

€368.40

argenx

7D

-5.1%

1Y

26.8%

MITRA

€2.33

Mithra Pharmaceuticals

7D

-15.8%

1Y

-69.0%

IBAB

€15.28

Ion Beam Applications

7D

-2.2%

1Y

-0.5%

OXUR

€0.0053

Oxurion

7D

35.9%

1Y

-98.6%

AGFB

€2.53

Agfa-Gevaert

7D

-5.4%

1Y

-35.3%

NYXH

€7.16

Nyxoah

7D

6.9%

1Y

-39.3%

ONWD

€5.70

Onward Medical

7D

16.8%

1Y

-15.6%

MDXH

€0.34

MDxHealth

7D

-5.0%

1Y

-53.9%

SEQUA

€3.23

Sequana Medical

7D

5.9%

1Y

-43.5%

TUB

€69.10

Financière de Tubize

7D

-8.5%

1Y

-11.1%

UCB

€79.32

UCB

7D

-7.6%

1Y

-3.5%

BIOS

€0.12

BioSenic

7D

4.7%

1Y

n/a